Human Papillomavirus Testing and Liquid-Based Cytology: Results at Recruitment From the New Technologies for Cervical Cancer Randomized Controlled Trial
Guglielmo Ronco,Nereo Segnan,Paolo Giorgi-Rossi,Marco Zappa,Gian Piero Casadei,Francesca Carozzi,Paolo Dalla Palma,Annarosa Del Mistro,Stefania Folicaldi,Anna Gillio-Tos,Gaetano Nardo,Carlo Naldoni,Patrizia Schincaglia,Manuel Zorzi,Massimo Confortini,Jack Cuzick +15 more
323
TL;DR: HPV testing alone was more sensitive than conventional cytology among women 35-60 years old and HPV testing using Hybrid Capture 2 with a 2 pg/mL cutoff may be more appropriate than a 1 pg/ mL cutoff for primary cervical cancer screening.
read more
Abstract: Background: Although testing for human papillomavirus (HPV) has higher sensitivity and lower specifi city than cytology alone for detecting cervical intraepithelial neoplasia (CIN), studies comparing conventional and liquid-based cytology have had confl icting results. Methods: In the fi rst phase of a two-phase multicenter randomized controlled trial, women aged 35 – 60 years in the conventional arm ( n = 16 658) were screened using conventional cytology, and women in the experimental arm ( n = 16 706) had liquidbased cytology and were tested for high-risk HPV types using the Hybrid Capture 2 assay. Women in the conventional arm were referred to colposcopy with atypical cells of undetermined signifi cance (ASCUS) or higher and those in the experimental arm were referred with ASCUS or higher cytology or with a positive ( ≥ 1 pg/mL) HPV test. Sensitivity and positive predictive value (PPV) for detection of cervical intraepithelial neoplasia grade 2 or higher (CIN2+) were calculated. Results: The screening methods and referral criterion applied in the experimental arm had higher sensitivity than that in the conventional arm (relative sensitivity = 1.47; 95% confi dence interval [CI] = 1.03 to 2.09) but a lower PPV (relative PPV = 0.40; 95% CI = 0.23 to 0.66). With HPV testing alone at ≥1 pg/mL and at ≥2 pg/mL, the gain in sensitivity compared with the conventional arm remained similar (relative sensitivity = 1.43, 95% CI = 1.00 to 2.04 and relative sensitivity = 1.41, 95% CI = 0.98 to 2.01, respectively) but PPV progressively improved (relative PPV = 0.58, 95% CI = 0.33 to 0.98 and relative PPV = 0.75, 95% CI = 0.45 and 1.27, respectively). Referral based on liquid-based cytology alone did not increase sensitivity compared with conventional cytology (relative sensitivity = 1.06; 95% CI = 0.72 to 1.55) but reduced PPV (relative PPV = 0.57; 95% CI = 0.39 to 0.82). Conclusions: HPV testing alone was more sensitive than conventional cytology among women 35 – 60 years old. Adding liquid-based cytology improved sensitivity only marginally but increased false-positives. HPV testing using Hybrid Capture 2 with a 2 pg/mL cutoff may be more appropriate than a 1 pg/mL cutoff for primary cervical cancer screening. [J Natl Cancer Inst 2006;98:765 – 74]
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
Citations
Is HPV DNA testing specificity comparable to that of cytological testing in primary cervical cancer screening? Results of a meta‐analysis of randomized controlled trials
TL;DR: Main key finding of the study is that in women aged ≥30, has been found an almost overlapping specificity between the two screening tests in detecting CIN2 and above‐grade lesions, suggesting primary screening of cervical cancer by HPV DNA testing appears to offer the right balance between maximum detection of CIN 2+ and adequate specificity.
45
Liquid-based cytology and human papillomavirus testing: A pooled analysis using the data from 13 population-based cervical cancer screening studies from China
Qin-Jing Pan,Shang-Ying Hu,Huiqin Guo,Wen-hua Zhang,Xun Zhang,Wen Chen,Jian Cao,Yong Jiang,Fang-Hui Zhao,You-Lin Qiao +9 more
TL;DR: The results of the current study support the use of the cervical cancer screening guidelines in China because LBC and HR-HPV cotesting had the highest sensitivity and negative predictive value (NPV) and could permit a safe extension of screening intervals.
44
Primary HPV screening for cervical cancer prevention: results from European trials
Elsebeth Lynge,Matejka Rebolj +1 more
TL;DR: Six European, randomized, controlled trials that will compare human papillomavirus (HPV) testing with cytological testing for cervical screening are under way and the results published so far are reviewed to compare the benefits and costs for participating women.
43
HPV DNA Testing for Cervical Cancer Screening
TL;DR: There is a need to improve screening both in low-resource settings where cytology is not widely available as well as in industrialized countries that have well established cervical cancer screening programs.
40
New paradigms in cervical cancer prevention: opportunities and risks.
TL;DR: An overview of the plausible impact of new technologies in cervical cancer screening in the near future and in the vaccinated cohorts is proposed.
References
Categorical Data Analysis
TL;DR: In this article, categorical data analysis was used for categorical classification of categorical categorical datasets.Categorical Data Analysis, categorical Data analysis, CDA, CPDA, CDSA
15.1K
Reliable estimation of generalized linear mixed models using adaptive quadrature.
TL;DR: A multilevel version ofthismethodin gllamm is implemented, a program that fits a large class of multileVEL latent variable models including multilesvel generalized linear mixed models, and it is shown that adaptive quadrature works well in problems where ordinary quadratures fails.
699
Management of women who test positive for high-risk types of human papillomavirus: The HART study
Jack Cuzick,Anne Szarewski,Heather Cubie,G Hulman,Henry C Kitchener,David Luesley,Euphemia McGoogan,Usha Menon,George Terry,Robert Edwards,Claire Brooks,Mina Desai,C Gie,Linda Lee Ho,Ian Jacobs,C Pickles,Peter Sasieni +16 more
TL;DR: Comparison of the detection rate and positive predictive values of HPV assay with cytology and the best management strategy for HPV-positive women found HPV testing was more sensitive than borderline or worse cytology but less specific for detecting CIN2+.
589
Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral.
Shalini L. Kulasingam,James P. Hughes,Nancy B. Kiviat,Constance Mao,Noel S. Weiss,Jane Kuypers,Laura A. Koutsky +6 more
TL;DR: Testing for HPV has higher sensitivity but lower specificity than thin-layer Pap screening, and screening for HPV DNA may be a reasonable alternative to cytology-based screening of reproductive-age women in some settings.
508